Press Releases

 Filter by Provider

Pitel brings 25 years of experience in technology and renewable energy, leveraging his in-depth understanding of the Brazilian market to manage business relationships with a lean, innovative, customer-focused mindset

ATLANTA, April 28, 2025 (GLOBE NEWSWIRE) -- Shiplify, the primary accessorial revenue identifier for carriers, shippers and third-party logistics (3PL) providers, today announced that the company’s President, North Winship, has been named a Top Transportation Innovator Pro to Know by Supply and Demand Chain Executive and Food Logistics. The Pros to Know Award recognizes individuals whose achievements serve as guides for other leaders looking to drive success through supply chain innovation.

AppOmni, the leader in SaaS security, today announced that AskOmni, its AI-powered SaaS security companion, now operates as a Model Context Protocol (MCP) server. Built using the open source MCP that provides a standard interface for AI models to interact with external systems, this pivotal advancement enables seamless integration with security-focused AI agents and security platforms such as Security Information and Event Monitoring (SIEM), Network Detection and Response (NDR), Extended Detection and Response (XDR), and Identity and Access Management (IAM) solutions. The AppOmni MCP server provides deep insights into SaaS identities, security posture, data exposures, and user behaviors to enable unparalleled threat investigations and analysis across the SaaS domain using agentic AI.

Endava (NYSE: DAVA), the technology-driven business transformation group whose AI-native approach combines cutting edge technology with deep industry expertise, today announced that it has joined OpenAI’s exclusive Beta Services Partner Program.

Ancestry will work with HBCUs to preserve their historical documents and rarely seen photography

Ft. Lauderdale, Florida--(Newsfile Corp. - April 28, 2025) - OptimumBank Holdings, Inc. (NYSE American: OPHC) announced today that it will...

Peachtree Group (“Peachtree”) has successfully secured U.S. Citizenship and Immigration Services (“USCIS”) approval for four regional centers: Peachtree South Regional Center, Peachtree Northeast Regional Center, Peachtree Midwest Regional Center and Peachtree West Regional Center. These approvals allow Peachtree to independently structure and sponsor EB-5 projects within the designated territories, streamlining the investment process and enhancing efficiency in bringing deals to market.

Putnam Managed Municipal Income Trust (NYSE: PMM), Putnam Master Intermediate Income Trust (NYSE: PIM), Putnam Municipal Opportunities Trust (NYSE: PMO) and Putnam Premier Income Trust (NYSE: PPT) (a “Fund” individually or together, the “Funds”) announced today the results of the votes cast at each Fund’s annual meeting of shareholders held April 25, 2025.

The "Connected POS Terminals - 8th Edition" report has been added to ResearchAndMarkets.com's offering.

During the RSA Conference in San Francisco, Dutch tech company LiveDrop introduced an innovative 'software-based data diode'. This solution behaves exactly like a real data diode and offers the same high level of security as traditional hardware data diodes, but without the associated cost and complexity. This 'software-based data diode' provides companies with a scalable and efficient way to protect their systems against data leaks and attacks.

TALLAHASSEE, FLORIDA / ACCESS Newswire / April 28, 2025 / Reese Gourley, a Florida State University student who survived the tragic shooting on April 17th, 2025, is speaking out for the first time as she continues to recover from her injuries. Reese suffered a gunshot wound to the back and now faces a long, difficult journey of physical and emotional healing. Ms. Gourley and her family are represented by attorney Carrie Mendrick Roane at Fasig | Brooks Law Offices.FSU Shooting Survivor Reese Gourley

Nuvve Holding Corp. (NASDAQ: NVVE), a leader in grid modernization and vehicle-to-grid (V2G) technology, today announced a new wholly owned subsidiary dedicated to building a cryptocurrency digital treasury along with cash flowing blockchain opportunities as part of a long-term strategic digital asset initiative.

The law firm of Robbins Geller Rudman & Dowd LLP announces that purchasers or acquirers of Ibotta, Inc. (NYSE: IBTA) publicly traded securities pursuant and/or traceable to Ibotta’s registration statement and related prospectus issued in connection with Ibotta’s initial public offering (the “IPO”) held on or around April 18, 2024, have until June 16, 2025 to seek appointment as lead plaintiff of the Ibotta class action lawsuit. Captioned Fortune v. Ibotta, Inc., No. 25-cv-01213 (D. Colo.), the Ibotta class action lawsuit charges Ibotta as well as certain of Ibotta’s top executives and directors, as well as the underwriters of the IPO, with violations of the Securities Act of 1933.

PROS® (NYSE: PRO), a leading provider of AI-powered SaaS pricing and selling solutions, today announced that it will host an Investor Q&A Session at Outperform with PROS 2025, its annual user conference.

The "Nigeria Construction Industry Databook Series - Market Size & Forecast by Value and Volume, Q1 2025 Update" has been added to ResearchAndMarkets.com's offering.

Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations.

SAN DIEGO, CA - April 28, 2025 (NEWMEDIAWIRE) - Quantumzyme Corp. (OTC: QTZM), a biotechnology company leveraging computational enzyme engineering, is pleased to announce the key benefits and commercialization avenues of its soon to be published patented enzymatic process for sustainable ibuprofen production. This innovation not only strengthens Quantumzyme’s leadership in green chemistry but also positions the company to capitalize on the global shift toward cleaner, more efficient manufacturing technologies. 

The "KRAS Inhibitors Market, Drug Sales, Patent, Price & Clinical Trials Insight 2030" report has been added to ResearchAndMarkets.com's offering.

Datavault AI Inc. (NASDAQ: DVLT), leading the way in AI data experience, valuation and monetization, announces its continued collaboration with NFL Alumni Health at the organization’s 16th Annual Draft Week event on April 24, 2025. The initiative featured Datavault AI’s patented ADIO® tone technology in two unique capacities: delivering interactive tones in sync with the top draft picks during the official watch party and sending geo-targeted health messages across the broader event to raise awareness around cardiovascular risks facing former athletes.

Niagen Bioscience, Inc. (NASDAQ: NAGE) (formerly ChromaDex Corp.), the global authority on NAD+ (nicotinamide adenine dinucleotide) with a focus on the science of healthy aging, announces that it will hold a conference call on Wednesday, May 7, 2025, at 4:30 p.m. ET to discuss its financial results for the first quarter 2025, which ended March 31, 2025. The financial results will be reported in a press release after the close of regular stock market trading hours on Wednesday, May 7, 2025.

CareXM, the leading provider of clinical triage and virtual care coordination solutions for post-acute care, announced today the launch of its Artificial Intelligence Decision Assistant, AIDA, an AI-powered tool designed to guide triage and make home-based care coordination between staff, patients, families, and ancillary services partners easier, safer, and faster.

PHILADELPHIA, April 28, 2025 (GLOBE NEWSWIRE) -- Berger Montague PC advises investors that a securities class action lawsuit has been filed against BigBear.ai Holdings, Inc. (“BigBear” or the “Company”) (NYSE: BBAI) on behalf of purchasers of BigBear securities between March 31, 2022 through March 25, 2025, inclusive (the “Class Period”).

Beverly Hills California () April 28, 2025 -- Hosted by hedge fund industry veteran Patrice Bonfiglio, The Burnout Club Podcast confronts burnout with real stories and expert insights - Powered by Mission Matters Media

The "Australia Construction Industry Databook Series - Market Size & Forecast by Value and Volume, Q1 2025 Update" has been added to ResearchAndMarkets.com's offering.

Patent Expands and Strengthens Intellectual Property Portfolio Around a Swallowable and Degradable Intragastric Device

TORONTO, April 28, 2025 (GLOBE NEWSWIRE) -- Hudbay Minerals Inc. (“Hudbay” or the “Company”) (TSX, NYSE: HBM) today announced the signing of an agreement with the Mosakahiken Cree Nation (“MCN”) on exploration activities in their traditional and ancestral territory, including at Hudbay’s Talbot deposit south of Snow Lake, Manitoba.

Conference Call to be Held Wednesday, May 7, 2025, at 10:00 a.m. ET

New integration gives users direct access to pre-bonded tokens on Solana, reducing barriers for early participation

Starting Friday, March 7, 2025, Blue Sky Scrubs invites nurses, physicians, healthcare workers, and their colleagues to participate in a heartfelt social media campaign designed to share the stories, pride, and power of women in healthcare. The first 100 participants to post a TikTok or Instagram video from their workplace, sharing what being a woman nurse—or supporting women nurses—means to them, will receive a free, premium designer scrub cap from Blue Sky Scrubs.

Exclusive Polls Capture Concerns from Providers, Hospitals, Health Systems, Payers, and More on Budget Cuts, Reimbursement Rules, and Tariff Impacts Amid Ongoing Policy Shifts

Initial order in Europe highlights Ondas' continued momentum as an emerging defense technology prime contractor, delivering next-generation autonomous systems to address evolving aerial threats and support critical national security operations

ImmunityBio, Inc. (NASDAQ: IBRX), a leading immunotherapy company, today announced positive long-term results from its QUILT-3.032 study of ANKTIVA® (nogapendekin alfa inbakicept-pmln) plus Bacillus Calmette-Guérin (BCG) for the treatment of adult patients with BCG-unresponsive non-muscle invasive bladder cancer (NMIBC) carcinoma in situ (CIS), with or without papillary disease. The findings were shared during an oral presentation at the American Urological Association Annual Meeting (AUA 2025) in Las Vegas, April 26-29.

Mirum Pharmaceuticals, Inc. (NASDAQ: MIRM) today announced that it will present data at three upcoming medical congresses. Digestive Disease Week (DDW) will be held in San Diego, May 3-6, 2025. The European Association for the Study of the Liver (EASL) will take place May 7-10 in Amsterdam, the Netherlands. The 57th European Society for Paediatric, Gastroenterology, Hepatology, and Nutrition (ESPGHAN) Annual Meeting will follow May 14-17 in Helsinki, Finland. Data from Mirum’s LIVMARLI and volixibat studies will be highlighted in oral and poster presentations during the congresses.

Employers and health plans are actively responding to the challenge of rising specialty drug costs, according to the newly-released 2025 Trends in Specialty Drug Benefits Report from Pharmaceutical Strategies Group (“PSG”), an EPIC company. The report was co-sponsored by Genentech and has been published for 12 years. Based on in-depth survey responses from more than 230 pharmacy benefit leaders, the report provides a comprehensive look at how organizations are managing complex, high-cost therapies and exploring innovative specialty drug management strategies.

Delcath Systems, Inc. (NASDAQ: DCTH), an interventional oncology company focused on the treatment of primary and metastatic liver cancers, today announced that the U.S. Food and Drug Administration (FDA) has completed its 30-day review of the Company's Investigational New Drug (IND) application for a Phase 2 clinical trial evaluating HEPZATO™ in combination with standard of care (SOC) for liver-dominant metastatic breast cancer (mBC). With the FDA's review complete, Delcath is now cleared to initiate patient enrollment in the U.S.

Odyssey Marine Exploration, Inc. (NASDAQ: OMEX), a U.S.-based leader in ocean exploration and sustainable mineral resource development, is pleased to see the issuance of a new Executive Order titled Unleashing America’s Offshore Critical Minerals and Resources. In addition, the company confirms that it currently has no specific plans to issue any securities under its universal shelf registration statement on Form S-3, which has been declared effective by the Securities and Exchange Commission (SEC) and provides Odyssey with the flexibility to access the capital markets in a timely manner. The specifics of any future offering, along with the prices and terms of any such securities offered by Odyssey, will be determined at the time of any such offering and will be described in detail in a prospectus supplement filed in connection with such offering. As previously announced, Odyssey currently anticipates that the proceeds from the Securities Purchase Agreement (SPA) executed by the company in December 2024, together with other prior funding arrangements, will continue to fund the company’s operations during 2025.

Mainstay Medical Holdings plc today announced that Anthem Blue Cross and Blue Shield (“Anthem”) has established favorable coverage for the company’s ReActiv8 Restorative NeurostimulationTM therapy for the treatment of intractable chronic low back pain. ReActiv8 is the only therapy considered medically necessary by the policy when the conditions for coverage are met. The coverage went into effect on April 16, 2025, and expands access to the procedure, when clinically appropriate, to Anthem’s policyholders.

Thermo Fisher Scientific, the world leader in serving science, is employing an enhanced platform technology and a new CHO K-1 cell line that can reduce timelines to Investigational New Drug (IND) filing from 13 to nine months, helping biotech and pharmaceutical companies overcome logistical complexities within pre-clinical biologic drug development.

Bank of Marin Bancorp, "Bancorp" (Nasdaq: BMRC), parent company of Bank of Marin, "Bank," announced net income of $4.9 million for the first quarter of 2025, compared to net income of $6.0 million for the fourth quarter of 2024 and $2.9 million for the first quarter of the prior year. Diluted earnings per share was $0.30 for the first quarter, compared to $0.38 for the prior quarter and $0.18 for the first quarter of prior year, a 67% increase, year over year.

New York, New York--(Newsfile Corp. - April 28, 2025) -  KPMG's latest Consumer Pulse Summer 2025 report paints a sobering...

Silver Spring, Maryland--(Newsfile Corp. - April 28, 2025) -  BTCS Inc. (NASDAQ: BTCS) ("BTCS" or the "Company"), a blockchain technology-focused...

Corticale SRL, a neurotechnology company developing minimally invasive brain-machine interfaces powered by high-resolution brain activity monitoring technology, today announced the publication of a study in Advanced Science that demonstrated the unmatched precision and depth of its SiNAPS (Simultaneous Neural Active Pixel Sensors) neural probes for large-scale brain mapping and brain-computer interface (BCI) development. The publication is titled “Multi-Shank 1024 Channels Active SiNAPS Probe for Large Multi-Regional Topographical Electrophysiological Mapping of Neural Dynamics.”

Kraken, one of the world’s most trusted and longest-standing cryptocurrency platforms with more than 15 million global clients, now offers US securities to US-residing clients. By expanding their product offering, Kraken continues to bridge the gap between digital and traditional assets– furthering their position as an institutional grade, multi-asset-class trading platform.

Tempus AI, Inc. (NASDAQ: TEM), a technology company leading the adoption of AI to advance precision medicine and patient care, today announced Tempus Loop, a new oncology-focused platform for target discovery and validation. Loop is Tempus’ proprietary approach to novel target identification that integrates real-world patient data (RWD) with human-derived biological models and CRISPR-screens, all leveraging AI to rapidly uncover insights for pre-clinical therapeutic development.

Asahi Kasei Bioprocess America, Inc. (AKBA), a leader in advanced filtration and fluid management solutions for the biopharmaceutical industry, has been recognized with the Best Technologies Innovation Award at INTERPHEX 2025. This recognition was for AKBA’s THESYS® Cleavage & Deprotection (C&D) and Tangential Flow Filtration (TFF) unit, a groundbreaking system redefining oligonucleotide manufacturing efficiency.

Ambac Financial Group, Inc. (NYSE: AMBC), an insurance holding company, today announced that it will release first quarter 2025 results on May 12, 2025, following the close of the market.

Alpha Cognition Inc. (NASDAQ: ACOG) (the “Company” or “Alpha Cognition”) today announced three upcoming presentations at the 2025 Alzheimer’s Association International Conference (the “AAIC”), taking place July 27–31, 2025 in Toronto, Canada.

Plastec Technologies, Ltd. (OTCBB: PLTYF) (the “Company”) today reported audited financial results for the fiscal year ended December 31, 2024.

Similarweb Ltd. (NYSE: SMWB), a leading digital data and web analytics company, today announced it will release first quarter 2025 financial results for the period ended March 31, 2025, on Tuesday, May 13, 2025, after the close of trading on the New York Stock Exchange.

WINTER SPRINGS, Fla., April 28, 2025 (GLOBE NEWSWIRE) -- IRADIMED CORPORATION (NASDAQ: IRMD) announced today that the Company will release its 2025 first quarter financial results before the market opens on Friday, May 5, 2025. Iradimed management will host a conference call the same day beginning at 9:00 a.m. Eastern Time to discuss those results and to answer questions.